:::

碩博士班簡介

:::

Research priorities

Cancer has been the leading cause of death in Taiwan since 1982. The age-standardized cancer incidence rate increased from 111 cases to 296.27 cases per 100,000 citizens between 1982 and 2010. More than 30,000 people die annually as a result of cancer. The impacts of cancer on quality of life, potential years of life lost and health care expenditures are tremendous. Finding strategies to prevent and treat cancer is one of the top priorities in medicine. All the faculty of the Program for Cancer Biology and Drug Discovery also contribute to the TMU Cancer Research Institute, which is dedicated to cancer prevention, detection and patient care. In accordance with our goals, we offer four multidisciplinary specialties to study specific kinds of cancer: breast cancer, colorectal cancer, prostate cancer and brain tumors.

 

The TMU cancer research institute is supported by its core facilities, Bioinformatics and the Health and Clinical Research Data Center (HCRDC). We aim to transform promising scientific discoveries into clinical applications by integrating medical information, basic science, treatment development and clinical research. These research results help us to discover more effective strategies to prevent, control and cure cancer.

cron web_use_log